Sanofi And Genzyme: Do Big Pharmas And Orphan Drugs Fit Together?
Executive Summary
Big pharmas from Pfizer to GlaxoSmithKline are expanding their initiatives in niche disease areas, but if Sanofi-Aventis acquires Genzyme as it hopes, the French drug maker could soon emerge as an orphan drug leader